Plant Health Share News (PHC)

Antisoma Profits, Revenues Rise After Transition To Investing Firm

Sierra Rutile Chairman increases stake to above 2m shares

Sierra Rutile's Non-Executive Chairman, Jan Castro, has swelled his stake in the mineral sands group to more than two million shares after a purchase made at the end of last week. Castro bought 627,500 shares at 50p a time, costing him a total of £313,750. A more modest purchase was made the sam

DIRECTOR DEALINGS: Plant Health Care Non-Exec Buys 21K Shares

DIRECTOR DEALINGS: Plant Health Care Non Executive Granted Options

Plant Health Care Loss Widens, But Revenues Rise

Telecity CEO sells shares as update impresses

Michael Tobin, the Chief Executive Officer of data centre operator Telecity, has sold 124,105 shares following the exercise of options over 125,105 shares, taking his stake to 666,000. The shares were traded in at 949.50p each, earning the director in the region of £1.18m. The deal was made on t

Carphone Warehouse heads partake in placing to fund acquisition

The Chairman, Chief Executive, and Chief Financial Officer (CFO) of mobile phones retailer Carphone Warehouse have all purchased shares as part of a placing, the proceeds of which are being used in part to fund the proposed acquisition of the remaining 50 per cent stake in CPW Europe. Sir Charles

Plant Health Care secures Arysta commercialisation deal - UPDATE

Plant Health Care (PHC), the developer of naturally derived agricultural products, has secured a long-awaited commercial contract with agrichemicals giant Arysta LifeScience Corporation. Following on from a research agreement between the two companies, the pair have agreed to develop and commercia

Plant Health Cares receives payment as partner reaches milestone

Shares in Plant Health Care (PHC) jumped on Wednesday after the company said that it will receive a payment after one of its partners reached a project milestone. PHC, the AIM-listed provider of biological products to the agriculture markets, said that Germains Seed Technology, its partner in devel

Plant Health warns on partnership revenues

Plant Health Care, the AIM-listed provider of naturally derived products to the agriculture industry, has warned that although it expects good growth in partnership revenues in the current year and next, these will be at lower levels than currently indicated by market forecasts. The announcement c

Plant Health Care seed test trials produce positive results

Biological products provider Plant Health Care has unveiled striking results relating to its Harpin seed trials. In a trading update providing details of its Harpin field trials, the group stated that the Harpin seed treatment had delivered substantial yield increases when combined with industry st

Plant Health Care says annual losses lower than expected

Plant Health Care said on Thursday it expects annual results to show an operating loss 'slightly better than expectations'. In a trading update, the provider of novel patent protected biological products to the global agriculture markets projected an operating loss of $6.5m for the year to the end

Plant Health Care delivers 'outstanding' results

Plant Health Care, a provider of innovative patent protected biological products to the global agriculture markets, has reported strong first sales of a novel approach to fungicide resistance management. Its ProAct product was applied to around 200,000 acres of crops in the US this season, produc

Small caps round-up: Manroy, Plant Health Care, Goals Soccer Centres

Six-a-side football pitches operator Goals Soccer Centres has won an appeal against a ruling made by HMRC, resulting in a boost to full year profits. Earlier in the year HMRC issued a business brief relating to the five-a-side soccer industry, indicating that all income relating to commercially oper

SDL non-exec takes up only holding in firm

Mandy Gradden, a non-executive director of SDL, the FTSE 250 information management firm, bought up 7,500 shares on Thursday, just over a week after the company unveiled a 20 per cent leap in first-half revenues. Gradden's purchase, in which she bought the shares at 658p each for a total of £49,35